What is the recommended dosing regimen for OxyContin (extended‑release oxycodone) in an opioid‑naïve adult with moderate‑to‑severe chronic pain, including initial dose, dosing interval, and adjustments for frail or elderly patients?

OxyContin Dosing for Opioid-Naïve Adults with Chronic Pain

For opioid-naïve adults with moderate-to-severe chronic pain, initiate OxyContin at 10 mg orally every 12 hours, with consideration of starting at 5 mg (half tablet) in frail or elderly patients. 1

Initial Dosing Strategy

The FDA-approved starting regimen is straightforward:

• Standard adult dose: 10 mg every 12 hours 1
• Frail/elderly patients: 5 mg (half tablet) every 12 hours, representing one-third to one-half the standard starting dose 1
• Route: Oral administration only; tablets must be swallowed whole—never cut, broken, chewed, crushed, or dissolved 1

Critical safety point: OxyContin is an extended-release formulation and should never be used for initial opioid titration in truly opioid-naïve patients. The most recent NCCN guidelines 2 and CDC guidelines 3 explicitly recommend starting with immediate-release opioids (5-15 mg immediate-release morphine or equivalent) for initial dose-finding, then converting to extended-release formulations only after stable pain control is achieved.

Dosing Interval

OxyContin is dosed every 12 hours as the standard regimen 1. However, real-world evidence challenges this:

• Research shows that 67% of chronic pain patients require more frequent dosing than every 12 hours, with 93% of these patients needing every-8-hour administration 4
• Patients on twice-daily dosing were twice as likely to require regularly scheduled breakthrough medications 4
• Despite manufacturer recommendations, clinical practice often necessitates every-8-hour dosing for adequate pain control

Titration Protocol

Adjust doses every 1-2 days based on pain control and adverse effects 1:

• Adults: Increase by 25-50% of current total daily dose when clinically indicated 1
• Breakthrough pain: Provide immediate-release opioid rescue doses equivalent to 10% of total daily oxycodone dose, available every hour for up to 4 consecutive hours before reassessment 5
• Steady-state: Achieved within 24 hours (significantly faster than morphine's 2-7 days) 6

Research demonstrates that controlled-release oxycodone can be titrated as effectively as immediate-release formulations, with 85-91% of patients achieving stable pain control 7. Pain intensity typically decreases by 57% within the first week and 72% by study end 8.

Special Population Adjustments

Elderly and Frail Patients

Start at one-third to one-half the standard dose 1:

• Initial dose: 5 mg every 12 hours
• Slower titration intervals recommended 9
• Monitor closely for cognitive effects, fall risk, and constipation 10
• Age-related pharmacokinetic changes (reduced renal/hepatic clearance, altered body composition) necessitate conservative dosing 10

Renal/Hepatic Impairment

Initiate at one-third to one-half the recommended starting dose 1:

• Active metabolites (oxymorphone, noroxycodone) can accumulate 2, 6
• Extended dosing intervals may be necessary
• More frequent monitoring required

Critical Safety Considerations

Opioid Tolerance Requirements

OxyContin doses ≥60 mg tablets, single doses >40 mg, or total daily doses >80 mg are ONLY for opioid-tolerant patients 1. Opioid tolerance is defined as taking for ≥1 week:

• ≥60 mg oral morphine daily
• ≥25 mcg/hour transdermal fentanyl
• ≥30 mg oral oxycodone daily
• ≥8 mg oral hydromorphone daily
• Or equianalgesic doses of other opioids 1

Contraindications to Extended-Release Initiation

The 2022 CDC guidelines 3 and 2025 NCCN guidelines 2 emphasize:

• Never initiate opioid therapy with extended-release formulations in truly opioid-naïve patients
• Extended-release opioids should be reserved for patients already receiving ≥60 mg oral morphine equivalents daily for ≥1 week
• Start with immediate-release opioids for dose-finding, then convert to extended-release

Metabolic Considerations

CYP2D6 poor metabolizers may have inadequate analgesic response to oxycodone 11. While oxycodone itself is active, conversion to the more potent metabolite oxymorphone via CYP2D6 contributes to analgesia. Consider alternative opioids (hydromorphone, morphine) if inadequate response occurs despite dose escalation.

Practical Algorithm

1. Confirm appropriateness: Patient should ideally be opioid-tolerant or have failed immediate-release opioid titration
2. Assess frailty/age: If elderly or frail → start 5 mg q12h; otherwise → 10 mg q12h
3. Evaluate organ function: If renal/hepatic impairment → reduce initial dose by 33-50%
4. Provide breakthrough medication: Immediate-release oxycodone 10% of total daily dose
5. Titrate every 1-2 days: Increase by 25-50% of total daily dose based on pain scores and adverse effects
6. Monitor for inadequate duration: If requiring >4 breakthrough doses daily or pain control <8 hours → consider every-8-hour dosing
7. Reassess regularly: Evaluate continued need, effectiveness, and development of tolerance or adverse effects

Common Pitfalls

• Using OxyContin for initial opioid exposure: This violates current guidelines and increases overdose risk 2, 3
• Inadequate breakthrough medication: Failure to provide immediate-release rescue doses leads to poor pain control
• Rigid adherence to q12h dosing: Clinical reality often requires q8h dosing despite labeling 4
• Crushing/breaking tablets: This converts extended-release to immediate-release, risking fatal overdose 1
• Ignoring pharmacogenomics: CYP2D6 poor metabolizers may need alternative opioids 11